290 related articles for article (PubMed ID: 7970158)
21. Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia.
Zhan SS; Beyreuther K; Schmitt HP
Dementia; 1993; 4(2):66-74. PubMed ID: 8358515
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff SW; Price DA
J Alzheimers Dis; 2006; 9(3 Suppl):101-15. PubMed ID: 16914849
[TBL] [Abstract][Full Text] [Related]
23. Long-term synaptic alteration in the rat hippocampal CA3 field following an entorhinal cortex lesion.
Miwa C; Ueki A; Shinjo H; Simode H; Morita Y
Psychiatry Clin Neurosci; 2001 Dec; 55(6):573-8. PubMed ID: 11737789
[TBL] [Abstract][Full Text] [Related]
24. Prion protein expression in senile plaques in Alzheimer's disease.
Ferrer I; Blanco R; Carmona M; Puig B; Ribera R; Rey MJ; Ribalta T
Acta Neuropathol; 2001 Jan; 101(1):49-56. PubMed ID: 11194941
[TBL] [Abstract][Full Text] [Related]
25. Synapse alteration in hippocampal CA3 field following entorhinal cortex lesion.
Ueki A; Miwa C; Shinjo H; Kokai M; Morita Y
J Neurol Sci; 1997 Oct; 151(1):1-5. PubMed ID: 9335002
[TBL] [Abstract][Full Text] [Related]
26. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain.
Wang D; Munoz DG
J Neuropathol Exp Neurol; 1995 Jul; 54(4):548-56. PubMed ID: 7602328
[TBL] [Abstract][Full Text] [Related]
27. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies.
Masliah E; Mallory M; DeTeresa R; Alford M; Hansen L
Brain Res; 1993 Jul; 617(2):258-66. PubMed ID: 8402154
[TBL] [Abstract][Full Text] [Related]
28. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
Masliah E; Iwai A; Mallory M; Uéda K; Saitoh T
Am J Pathol; 1996 Jan; 148(1):201-10. PubMed ID: 8546207
[TBL] [Abstract][Full Text] [Related]
29. Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease.
Masliah E; Mallory M; Hansen L; Alford M; DeTeresa R; Terry R; Baudier J; Saitoh T
Brain Res; 1992 Mar; 574(1-2):312-6. PubMed ID: 1386275
[TBL] [Abstract][Full Text] [Related]
30. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
31. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
32. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
34. A subset of calretinin-positive neurons are abnormal in Alzheimer's disease.
Brion JP; Résibois A
Acta Neuropathol; 1994; 88(1):33-43. PubMed ID: 7941970
[TBL] [Abstract][Full Text] [Related]
35. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
Masliah E; Terry RD; Alford M; DeTeresa R; Hansen LA
Am J Pathol; 1991 Jan; 138(1):235-46. PubMed ID: 1899001
[TBL] [Abstract][Full Text] [Related]
36. Phorbol ester-induced neuritic alterations in the rat neocortex. Structural and immunocytochemical studies.
Masliah E; Mallory M; Ge N; Godson C; Saitoh T
Mol Chem Neuropathol; 1993 Oct; 20(2):125-45. PubMed ID: 8297418
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC
Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of synaptic dysfunction in Alzheimer's disease.
Masliah E
Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
[TBL] [Abstract][Full Text] [Related]
39. Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field.
von Gunten A; Kövari E; Rivara CB; Bouras C; Hof PR; Giannakopoulos P
Exp Neurol; 2005 May; 193(1):198-206. PubMed ID: 15817278
[TBL] [Abstract][Full Text] [Related]
40. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
Ho GJ; Hashimoto M; Adame A; Izu M; Alford MF; Thal LJ; Hansen LA; Masliah E
Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
